1
2
3
4
5
6
7
8
9
10
11

Mirum Pharmaceuticals is dedicated to creating life-changing therapies for patients with liver diseases.

12
13
14
15
Extra 1

Our medicines are designed to address the severe itching and progressive liver damage of cholestatic liver diseases for children like Trey.

16
17
18

We don’t just work on behalf of patients, we work with them. We are currently recruiting patients for clinical trials.

Latest News

  • Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

    May 6, 2021

  • Mirum Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call on May 6, 2021

    April 29, 2021

  • Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China for Rare Liver Diseases

    April 29, 2021

  • Mirum Pharmaceuticals Receives Notice of Allowance for Methods of Use Patent for Maralixibat in Alagille Syndrome

    April 26, 2021

  • Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis

    April 12, 2021